Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe (Q56420565)
article
Language:
Current Data About Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe
(P31) (Q13442814)

(P50) (Q19859634)
(P1545) 10
(P1932) Paul Emery

(Q37829390)
(P1545) 2
(P1932) Philip G. Conaghan

(P304) 27-35

(P407) (Q1860)

(P433) 1

(P478) 52

(P577) +2005-01-00T00:00:00Z

(P921) (Q101929)

(Q327657)

(Q187255)
(P887)

(Q422232)
(P887)

(P1433) (Q23929027)

(P1476) "Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe" (language: en)

(P2093) Mark A. Quinn
(P1545) 1

Philip J. O'Connor
(P1545) 3

Zunaid Karim
(P1545) 4

Adam Greenstein
(P1545) 5

Andrew Brown
(P1545) 6

Clare Brown
(P1545) 7

Alexander Fraser
(P1545) 8

Stephen Jarret
(P1545) 9

other details
description article

External Links
(P356) 10.1002/ART.20712
(P698) 15641102
(P5875) 8090427